2 October 2026 · Medical Device Network
Brainomix e-Lung shows progression and treatment response in trial
Doctors & NHSeHealth & digital healthMedical businesses
Brainomix’s e-Lung has shown progression and treatment response in a Phase III trial. Trial operators are increasingly incorporating imaging and related artificial intelligence tools into study protocols.
Why it matters
The report is relevant to clinicians and digital health businesses following the use of imaging software in clinical research.
Protect your practice
Summary for general information only — not legal, clinical or insurance advice.